Corbion NV
Last update: February 2, 2021
Biotechnology
Netherlands
Its 32 main executivesIts subsidiary
Recent executive movements at Corbion NV
Stefanie Schmitz, Director, has left the company (news posted on September 14 2020).
Create an alert
to follow the executive moves at Corbion NV.
Corbion NV is one of the...
Most searched biographies at Corbion NV
- Olivier Rigaud, Chief Executive Officer
- Mathieu Vrijsen, Chairman of the Supervisory Board
- Jack de Kreij, Member of the Supervisory Board
Click on an executive to view his biography >
Latest M&A news in Biotechnology.
Amgen has announced the acquisition of Five Prime Therapeutics (posted on Mar 5, 2021).
Bio-Techne has announced the acquisition of Asuragen (posted on Mar 4, 2021).
Roivant Sciences has announced the acquisition of Silicon Therapeutics (posted on Feb 26, 2021).
Other contacts in the Biotechnology industry
Latest news about Corbion NV
Corbion to Expand Lactic Acid Capacity in North America
Corbion sells frozen dough business East Rutherford
Corbion recognized with prestigious ‘A’ score for climate change
Corbion to sell former location sugar factory to city of Breda and province Noord-Brabant
Corbion Q3 2020 Interim Management Statement
Corbion NV on Wikipedia, Google News & Yahoo Finance
Corbion NV on LinkedIn, Twitter & YouTube
Corbion NV has 1,569 competitors including Biogen (United States (USA)), Neptune Wellness Solutions (Canada) and Eurofins (France).
Contact by email its executives including Olivier Rigaud 
